Amoxicillin News
Axcan Receives FDA Approval Letter for PYLERA'TM' (Formerly Known as HELIZIDE), an Innovative 3-in-1 Capsule Triple Therapy for the Eradication of Helicobacter Pylori
Axcan Pharma Inc. today announced that the US Food and Drug Administration ("FDA") has issued an approval letter for the Company's New Drug Application for PYLERATM (formerly HELIZIDE). PYLERATM is a patented 3-in-1 capsule...
Advancis Pharmaceutical On Track to File NDA for Amoxicillin PULSYS
Advancis Pharmaceutical Corporation (Nasdaq: AVNC), a pharmaceutical company focused on developing and commercializing novel anti-infective products, today announced it has received correspondence from the U.S. Food and Drug...
Topical Ciprofloxacin/Dexamethasone Superior to Oral Amoxicillin/Clavulanic Acid in Acute Otitis Media With Otorrhea Through Tympanostomy Tubes
OBJECTIVE. This study was a comparison of topical ciprofloxacin/dexamethasone otic suspension to oral amoxicillin/clavulanic acid suspension in children with acute otitis media with otorrhea through tympanostomy tubes.
Penicillin and gentamicin therapy vs amoxicillin/clavulanate in severe hypoxemic pneumonia
Objective : To compare the efficacy of sequential injectable crystalline penicillin (C.pen) and gentamicin combination followed by oral amoxicillin with sequential IV and oral amoxicillin-clavulanate (amox-clav) in treatment of...
Effectiveness of discontinuing antibiotic treatment after three days versus eight days in mild to moderate-severe community acquired pneumonia: randomised, double blind study
To compare the effectiveness of discontinuing treatment with amoxicillin after three days or eight days in adults admitted to hospital with mild to moderate-severe community acquired pneumonia who substantially improved after an...